Delphine Galezowski

Co founder at Harmonix

Presenter

Delphine Galezowski is a biotech entrepreneur and former pharmaceutical industry executive with more than 10 years of international experience in oncology, hematology and healthcare innovation. Following leadership training at Harvard Business School, she founded Harmonix to address one of the major barriers in genetic medicines: efficient delivery to the central nervous system. She is focused on building strategic partnerships that accelerate the development of next-generation therapies for neurodegenerative and neurological diseases.